Last reviewed · How we verify
Samsoeum
Samsoeum is a Small molecule drug developed by Korean Medicine Hospital of Pusan National University. It is currently in Phase 1 development. Also known as: Hanpoong Samsoeum.
Samsoeum is a herbal medicine that has been studied in a clinical trial for the treatment of the common cold. This trial, conducted by the Korean Medicine Hospital of Pusan National University, compared the effectiveness and safety of Samsoeum to a placebo.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Samsoeum |
|---|---|
| Also known as | Hanpoong Samsoeum |
| Sponsor | Korean Medicine Hospital of Pusan National University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Samsoeum CI brief — competitive landscape report
- Samsoeum updates RSS · CI watch RSS
- Korean Medicine Hospital of Pusan National University portfolio CI
Frequently asked questions about Samsoeum
What is Samsoeum?
Who makes Samsoeum?
Is Samsoeum also known as anything else?
What development phase is Samsoeum in?
Related
- Manufacturer: Korean Medicine Hospital of Pusan National University — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Hanpoong Samsoeum
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing